LAMIZID 300mg Tablet 60s

Frequently asked questions

• Onset of action

  The time required for this medicine to show its effect is not clinically established.

• Duration of Effect

  The time until which this medicine remains active in the body is not clinically established.

• Safe with Alchohol?

  Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

• Is it habit forming?

  No habit forming tendency has been reported.

• Usage in pregnancy?

  This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

• Usage while breast-feeding?

  This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue the drug or to discontinue breastfeeding based on your clinical condition.

• Allergy

  This medicine is not recommended for use in patients with a known allergy to LAMIZID 300mg Tablet 60s , or any other inactive ingredients present along with these medicines.

• Renal impairment

  This medicine is not recommended for use in patients with creatinine clearance less than 50 ml/min due to the increased risk of serious adverse effects.

• Liver impairment

  This medicine is not recommended for use in patients with liver function impairment due to the increased risk of worsening of the patient's condition.

• Pregnancy

  This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

• Breast-feeding

  This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue the drug or to discontinue breastfeeding based on your clinical condition.

• Immune reconstitution syndrome

  This medicine should be used with caution due to the increased risk of Immune reconstitution syndrome. Report any unusual symptoms to the doctor immediately. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

• Lactic acidosis

  This medicine should be used with caution due to the increased risk of Lactic acidosis. Report any unusual symptoms to the doctor immediately. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

• Fat redistribution

  This medicine may cause fat gain or fat loss from the body. This may result in peripheral wasting, facial wasting, breast enlargement, and Cushingoid appearance. Close monitoring of body weight and body fat distribution is necessary while receiving this medicine. Any changes in the body should be informed to the doctor on priority. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

• Opportunistic infections

  Patients receiving this medicine may continue to develop opportunistic infections and other complications associated with HIV infections. These patients should be monitored closely during treatment with this medicine. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

• Osteonecrosis

  This medicine may cause osteonecrosis in some patients. This risk is particularly high in adult patients with advanced HIV-disease. Report any unusual symptoms such as joint stiffness, joint pain, difficulty with movements, etc. to the doctor immediately. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

• Pancreatitis

  This medicine may rarely cause pancreatitis in some patients. Report any unusual symptoms to the doctor immediately. Therapy may need to be discontinued if the patient develops any signs or symptoms of pancreatitis.

Take this medicine exactly as instructed by the doctor. Do not take in larger or smaller quantities than recommended. Ensure that proper hygiene measures are adopted. Complete the course of treatment to prevent the spread of the infection. Close monitoring of liver function and kidney function may be necessary while receiving this medicine based on the clinical condition.

• Can be taken with or without food, as advised by your doctor
• To be taken as instructed by doctor
• Does not cause sleepiness

• dailymed - LAMIVUDINE AND ZIDOVUDINE [Internet]. Available from: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3896c79b-8f02-4a77-bb80-e4aefc0deed7 [cited 2/12/2021]. 2016